Bank of America says employees’ GLP-1 drug use has driven more than $250 million in health care costs
A report cited by Yahoo Finance says the bank’s spending on GLP-1 medications for employees totals more than $250 million, and that GLP-1s represent about 13% of its overall health care spending.